RABBVAbbVie Tokenized Stock (Reality)
Stock 24/7/365Issued by Reality
AbbVie Inc. is a research-driven global biopharmaceutical powerhouse fortified by extensive intellectual property moats in immunology, oncology, and neuroscience. The corporation owns major blockbuster pipelines including Skyrizi and Rinvoq—the designated successors to its historic multi-billion-dollar immunology anchor Humira—alongside the leading medical aesthetics franchise Botox, maintaining superior gross margins globally.
- Macro context: RABBV is part of the tokenized equities market, which represents only ~0.002% of global listed equity today.
Data as of Nov 1, 2026
Price performance
7D
—
14D
—
30D
—
1Y
—
All-time
+10.26%
Key facts
via /coins/{id}Market Cap Rank
#10874
Circulating Supply
44.89
Total Supply
44.89
All-Time High
$298.26 · 2026-10-30
Categories
News & Insights
Also tokenized by
AbbVie Tokenized Stock (Reality) is issued as 5 separate tokens across different issuers.
ABBVX
ABBVON
ABBV
Alerts & digests
Coming soonReal-time price, NAV, mint, redemption alerts
Get pinged the moment RABBV crosses a price or spread threshold you set, or automated.
Breaking news alerts
Issuer, regulatory and depeg news for RABBV — the second it drops.
Daily summary
A once-a-day digest of RABBV's price, best yield and market moves in your inbox.
Analyze & download 24/7 history
Full round-the-clock historical data for RABBV — including off-market-hours — exportable to CSV.
Analyse with insight & news
AI-assisted analysis of RABBV paired with the latest issuer, regulatory and market news.